These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38215766)

  • 1. Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysis.
    Nimmo C; Bionghi N; Cummings MJ; Perumal R; Hopson M; Al Jubaer S; Naidoo K; Wolf A; Mathema B; Larsen MH; O'Donnell M
    Lancet Microbe; 2024 Feb; 5(2):e164-e172. PubMed ID: 38215766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: an individual isolate metaanalysis.
    Nimmo C; Bionghi N; Cummings MJ; Perumal R; Hopson M; Al Jubaer S; Wolf A; Mathema B; Larsen MH; O'Donnell M
    medRxiv; 2023 May; ():. PubMed ID: 37205550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants and their association with phenotypic resistance to bedaquiline in
    Ismail N; Rivière E; Limberis J; Huo S; Metcalfe JZ; Warren RM; Van Rie A
    Lancet Microbe; 2021 Nov; 2(11):e604-e616. PubMed ID: 34796339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis.
    Nimmo C; Millard J; van Dorp L; Brien K; Moodley S; Wolf A; Grant AD; Padayatchi N; Pym AS; Balloux F; O'Donnell M
    Lancet Microbe; 2020 Aug; 1(4):e165-e174. PubMed ID: 32803174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MmpR5 protein truncation and bedaquiline resistance in Mycobacterium tuberculosis isolates from South Africa: a genomic analysis.
    Roberts LW; Malone KM; Hunt M; Joseph L; Wintringer P; Knaggs J; Crook D; Farhat MR; Iqbal Z; Omar SV
    Lancet Microbe; 2024 Aug; 5(8):100847. PubMed ID: 38851206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline.
    Villellas C; Coeck N; Meehan CJ; Lounis N; de Jong B; Rigouts L; Andries K
    J Antimicrob Chemother; 2017 Mar; 72(3):684-690. PubMed ID: 28031270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region.
    Zimenkov DV; Nosova EY; Kulagina EV; Antonova OV; Arslanbaeva LR; Isakova AI; Krylova LY; Peretokina IV; Makarova MV; Safonova SG; Borisov SE; Gryadunov DA
    J Antimicrob Chemother; 2017 Jul; 72(7):1901-1906. PubMed ID: 28387862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations associated with in vitro resistance to bedaquiline in Mycobacterium tuberculosis isolates in Australia.
    Martinez E; Hennessy D; Jelfs P; Crighton T; Chen SC; Sintchenko V
    Tuberculosis (Edinb); 2018 Jul; 111():31-34. PubMed ID: 30029911
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Ismail N; Ismail NA; Omar SV; Peters RPH
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis.
    Brown TS; Tang L; Omar SV; Joseph L; Meintjes G; Maartens G; Wasserman S; Shah NS; Farhat MR; Gandhi NR; Ismail N; Brust JCM; Mathema B
    Clin Infect Dis; 2024 Feb; 78(2):269-276. PubMed ID: 37874928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variants associated with Bedaquiline (BDQ) resistance identified in Rv0678 and efflux pump genes in Mycobacterium tuberculosis isolates from BDQ naïve TB patients in Pakistan.
    Saeed DK; Shakoor S; Razzak SA; Hasan Z; Sabzwari SF; Azizullah Z; Kanji A; Nasir A; Shafiq S; Ghanchi NK; Hasan R
    BMC Microbiol; 2022 Feb; 22(1):62. PubMed ID: 35209842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of a historic reservoir of bedaquiline/clofazimine resistance-associated variants in Mycobacterium tuberculosis.
    Nimmo C; Ortiz AT; Tan CCS; Pang J; Acman M; Millard J; Padayatchi N; Grant AD; O'Donnell M; Pym A; Brynildsrud OB; Eldholm V; Grandjean L; Didelot X; Balloux F; van Dorp L
    Genome Med; 2024 Feb; 16(1):34. PubMed ID: 38374151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates.
    Peretokina IV; Krylova LY; Antonova OV; Kholina MS; Kulagina EV; Nosova EY; Safonova SG; Borisov SE; Zimenkov DV
    J Infect; 2020 May; 80(5):527-535. PubMed ID: 31981638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants.
    Ismail N; Omar SV; Ismail NA; Peters RPH
    J Microbiol Methods; 2018 Oct; 153():1-9. PubMed ID: 30165087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in
    Singh BK; Soneja M; Sharma R; Chaubey J; Kodan P; Jorwal P; Nischal N; Chandra S; Ramachandran R; Wig N
    Int J Mycobacteriol; 2020; 9(2):212-215. PubMed ID: 32474547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure.
    Le Ray LF; Aubry A; Sougakoff W; Revest M; Robert J; Bonnet I; Veziris N; Morel F
    Emerg Infect Dis; 2022 May; 28(5):1062-1064. PubMed ID: 35447056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study.
    Derendinger B; Dippenaar A; de Vos M; Huo S; Alberts R; Tadokera R; Limberis J; Sirgel F; Dolby T; Spies C; Reuter A; Folkerts M; Allender C; Lemmer D; Van Rie A; Gagneux S; Rigouts L; Te Riele J; Dheda K; Engelthaler DM; Warren R; Metcalfe J; Cox H; Theron G
    Lancet Microbe; 2023 Dec; 4(12):e972-e982. PubMed ID: 37931638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid.
    Gómez-González PJ; Perdigao J; Gomes P; Puyen ZM; Santos-Lazaro D; Napier G; Hibberd ML; Viveiros M; Portugal I; Campino S; Phelan JE; Clark TG
    Sci Rep; 2021 Sep; 11(1):19431. PubMed ID: 34593898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characteristics and in vitro susceptibility to bedaquiline of Mycobacterium tuberculosis isolates circulating in Shaanxi, China.
    Yang J; Pang Y; Zhang T; Xian X; Li Y; Wang R; Wang P; Zhang M; Wang J
    Int J Infect Dis; 2020 Oct; 99():163-170. PubMed ID: 32738481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678.
    Snobre J; Villellas MC; Coeck N; Mulders W; Tzfadia O; de Jong BC; Andries K; Rigouts L
    Sci Rep; 2023 Jun; 13(1):10444. PubMed ID: 37369740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.